Literature DB >> 24022535

Utilization and safety of sodium hyaluronate-carboxymethylcellulose adhesion barrier.

Shazia Bashir1, Cande V Ananth, Sharyn N Lewin, William M Burke, Yu-Shiang Lu, Alfred I Neugut, Thomas J Herzog, Dawn L Hershman, Jason D Wright.   

Abstract

BACKGROUND: Little is known about the use and toxicity of antiadhesion substances such as sodium hyaluronate-carboxymethylcellulose.
OBJECTIVE: We analyzed the patterns of use and safety of sodium hyaluronate-carboxymethylcellulose in patients undergoing colectomy and gynecologic surgery.
DESIGN: This is a retrospective cohort study.
SETTING: This study covered hospitals nationwide. PATIENTS: All patients in the Premier Perspective database who underwent colectomy or hysterectomy from 2000 to 2010 were included in the analyses. MAIN OUTCOME MEASURE: Hyaluronate-carboxymethylcellulose use was determined by billing codes. For the primary outcome, we used hierarchical mixed-effects logistic regression models to determine the factors associated with the use of hyaluronate-carboxymethylcellulose, whereas a propensity score-matched analysis was used to secondarily assess the association between hyaluronate-carboxymethylcellulose use and toxicity (abscess, bowel and wound complications, peritonitis).
RESULTS: We identified 382,355 patients who underwent hysterectomy and 267,368 who underwent colectomy. For hysterectomy, hyaluronate-carboxymethylcellulose use was 5.0% overall, increasing from 1.1% in 2000 to 9.8% in 2010. Hyaluronate-carboxymethylcellulose was used in 8.1% of those who underwent colectomy and increased from 6.2% in 2000 to 12.4% in 2010. The year of diagnosis and procedure volume of the attending surgeon were the strongest predictors of hyaluronate-carboxymethylcellulose use. After matching and risk adjustment, hyaluronate-carboxymethylcellulose use was not associated with abscess formation (1.5% vs 1.5%) (relative risk = 0.97; 95% CI, 0.84-1.12) in those who underwent hysterectomy. A patient receiving hyaluronate-carboxymethylcellulose had a 13% increased risk of abscess (17.4% vs 15.0%) (relative risk = 1.13; 95% CI, 1.08-1.17) after colectomy. LIMITATIONS: This was an observational study.
CONCLUSION: Hyaluronate-carboxymethylcellulose use has increased over the past decade for colectomy and hysterectomy. Although there is no association between hyaluronate-carboxymethylcellulose use and abscess following hysterectomy, hyaluronate-carboxymethylcellulose use was associated with a small increased risk of abscess after colectomy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24022535      PMCID: PMC4624422          DOI: 10.1097/DCR.0b013e31829ec889

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  37 in total

1.  Effect of surgical adhesion reduction devices on the propagation of experimental intra-abdominal infection.

Authors:  A O Tzianabos; R L Cisneros; J Gershkovich; J Johnson; R J Miller; J W Burns; A B Onderdonk
Journal:  Arch Surg       Date:  1999-11

2.  Easy SAS calculations for risk or prevalence ratios and differences.

Authors:  Donna Spiegelman; Ellen Hertzmark
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

Review 3.  Peritoneal adhesions. Incidence, cause, and prevention.

Authors:  D Menzies
Journal:  Surg Annu       Date:  1992

4.  Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection.

Authors:  Victor W Fazio; Zane Cohen; James W Fleshman; Harry van Goor; Joel J Bauer; Bruce G Wolff; Marvin Corman; Robert W Beart; Steven D Wexner; James M Becker; John R T Monson; Howard S Kaufman; David E Beck; H Randolph Bailey; Kirk A Ludwig; Michael J Stamos; Ara Darzi; Ronald Bleday; Richard Dorazio; Robert D Madoff; Lee E Smith; Susan Gearhart; Keith Lillemoe; Jonas Göhl
Journal:  Dis Colon Rectum       Date:  2006-01       Impact factor: 4.585

5.  Perioperative beta-blocker therapy and mortality after major noncardiac surgery.

Authors:  Peter K Lindenauer; Penelope Pekow; Kaijun Wang; Dheeresh K Mamidi; Benjamin Gutierrez; Evan M Benjamin
Journal:  N Engl J Med       Date:  2005-07-28       Impact factor: 91.245

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Prevention of postoperative abdominal adhesions by a novel, glycerol/sodium hyaluronate/carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study.

Authors:  Zane Cohen; Anthony J Senagore; Merril T Dayton; Mark J Koruda; David E Beck; Bruce G Wolff; Phillip R Fleshner; Richard C Thirlby; Kirk A Ludwig; Sergio W Larach; Eric G Weiss; Joel J Bauer; Lena Holmdahl
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

8.  Small bowel obstruction due to postoperative adhesions: treatment patterns and associated costs in 110 hospital admissions.

Authors:  D Menzies; M Parker; R Hoare; A Knight
Journal:  Ann R Coll Surg Engl       Date:  2001-01       Impact factor: 1.891

9.  A randomized controlled trial of 0.5% ferric hyaluronate gel (Intergel) in the prevention of adhesions following abdominal surgery.

Authors:  Choong-Leong Tang; David G Jayne; Francis Seow-Choen; Yen-Yee Ng; Kong-Weng Eu; Noriza Mustapha
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

10.  A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine.

Authors:  David E Beck; Zane Cohen; James W Fleshman; Howard S Kaufman; Harry van Goor; Bruce G Wolff
Journal:  Dis Colon Rectum       Date:  2003-10       Impact factor: 4.585

View more
  2 in total

Review 1.  Adhesive small bowel adhesions obstruction: Evolutions in diagnosis, management and prevention.

Authors:  Fausto Catena; Salomone Di Saverio; Federico Coccolini; Luca Ansaloni; Belinda De Simone; Massimo Sartelli; Harry Van Goor
Journal:  World J Gastrointest Surg       Date:  2016-03-27

2.  Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression.

Authors:  Laetitia Picaud; Benoît Thibault; Eliane Mery; Monia Ouali; Alejandra Martinez; Jean-Pierre Delord; Bettina Couderc; Gwenael Ferron
Journal:  J Ovarian Res       Date:  2014-04-16       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.